Pioglitazonehydrochloride
Product Images NDC 53002-1756

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Pioglitazonehydrochloride (NDC 53002-1756). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021756)

Label for Pioglitazone Hydrochloride 30 mg tablets by RPK Pharmaceuticals, Inc. The product contains 30 tablets with instructions to take one tablet daily or as directed. The label includes prescription status, lot and expiration dates section, and spaces for patient and clinic information, along with storage and usage instructions.*

FDA Label Image

Structure (Pioglitazonetablets Figure 01)

Chemical structure of Pioglitazone Hydrochloride showing its molecular framework including aromatic rings, heteroatoms, and functional groups as represented in the diagram.*

FDA Label Image

Figure (Pioglitazonetablets Figure 02)

A line graph showing mean values over 26 weeks for four groups: Placebo, 15 mg, 30 mg, and 45 mg. The x-axis represents weeks, and the y-axis represents mean values. The graph illustrates different trends in mean values over time among the groups.*

FDA Label Image

Logo (Pioglitazonetablets Figure 03)

FDA Label Image

Logo (Pioglitazonetablets Figure 04)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.